Autoimmune Myopathies: Where Do We Stand? (Q26744554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

review article

1 reference

title

Autoimmune Myopathies: Where Do We Stand? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jeremie Martinet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Jean-Philippe Simon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Isabelle Marie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Fabienne Jouen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

14 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

published in

Frontiers in Immunology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27379096%20AND%20SRC:MED&resulttype=core&format=json

Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages

17 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Statin-Associated Autoimmune Myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Immune-mediated necrotizing myopathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Novel antibody associations in immune-mediated necrotising myopathy without inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

The clinical features, diagnosis and classification of dermatomyositis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Association of the autoimmune disease scleroderma with an immunologic response to cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Autoantibodies in polymyositis and dermatomyositis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Long-term observational study of sporadic inclusion body myositis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Acquired immune and inflammatory myopathies: pathologic classification

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Necrotizing autoimmune myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Therapy of polymyositis and dermatomyositis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylat

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Immunotherapy of myositis: issues, concerns and future prospects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Polymyositis and dermatomyositis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Polymyositis: an overdiagnosed entity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Recognition of tRNAs by aminoacyl-tRNA synthetases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Inclusion body myositis and myopathies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Human autoantibodies reactive with the signal-recognition particle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Polymyositis and dermatomyositis (first of two parts)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

The lymphoid follicle variant of dermatomyositis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905946

Inflammatory Muscle Diseases.

31 May 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Identification of a novel myositis-associated antibody directed against cortactin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Immune-mediated necrotizing myopathy associated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

A pilot randomized trial of oxandrolone in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Valosin-containing protein gene mutations: clinical and neuropathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2016.00234

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

21 January 2018

1 reference

12 December 2020

Unicorns, dragons, polymyositis, and other mythological beasts

1 reference

12 December 2020

Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells

1 reference

12 December 2020

beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis

1 reference

12 December 2020

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis

1 reference

12 December 2020

Expression of class I and class II MHC antigens in neuromuscular diseases

1 reference

12 December 2020

Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis

1 reference

12 December 2020

Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

1 reference

12 December 2020

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

1 reference

12 December 2020

Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2016.00234

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xen2lzjaubb4teme3spfp4nnua

30 July 2022

release_xen2lzjaubb4teme3spfp4nnua

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xen2lzjaubb4teme3spfp4nnua

30 July 2022

OpenCitations bibliographic resource ID

804069

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://api.fatcat.wiki/v0/release/xen2lzjaubb4teme3spfp4nnua

30 July 2022

https://api.fatcat.wiki/v0/release/xen2lzjaubb4teme3spfp4nnua

1 reference

30 July 2022